These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 18229572)
21. [The use of broncho-vaxom preparation in clinical practice]. Mierzejewska-Zawisza MJ; Jahnz-Rózyk K; Rabczuk J Pol Merkur Lekarski; 2003 May; 14(83):457-8. PubMed ID: 12939827 [TBL] [Abstract][Full Text] [Related]
22. Bacterial lysate add-on therapy to reduce exacerbations in severe asthma: A double-blind placebo-controlled trial. de Boer GM; Braunstahl GJ; van der Ploeg EK; van Zelst CM; van Bruggen A; Epping G; van Nimwegen M; Verhoeven G; Birnie E; Boxma-de Klerk BM; de Bruijn MJW; Stadhouders R; Hendriks RW; Tramper-Stranders GA Clin Exp Allergy; 2021 Sep; 51(9):1172-1184. PubMed ID: 34289183 [TBL] [Abstract][Full Text] [Related]
23. [Comments on Immune stimulation/-modulation with preparations consisting of extracts of Sun-flower or bacterial lysate]. Reinhardt D Monatsschr Kinderheilkd; 1993 Jul; 141(7):622. PubMed ID: 8413343 [No Abstract] [Full Text] [Related]
24. Bacterial lysates in the prevention of respiratory tract infections. Jurkiewicz D; Zielnik-Jurkiewicz B Otolaryngol Pol; 2018 Oct; 72(5):1-8. PubMed ID: 30460909 [TBL] [Abstract][Full Text] [Related]
25. Impact of a homeopathic medication on upper respiratory tract infections in COPD patients: Results of an observational, prospective study (EPOXILO). Conde Diez S; Viejo Casas A; Garcia Rivero JL; Lopez Caro JC; Ortiz Portal F; Diaz Saez G Respir Med; 2019 Jan; 146():96-105. PubMed ID: 30665525 [TBL] [Abstract][Full Text] [Related]
26. [Prospective placebo-controlled double-blind study using a bacterial lysate in infections of the respiratory tract and ENT region in children]. Schaad UB; Farine JC; Fux T Helv Paediatr Acta; 1986 May; 41(1-2):7-17. PubMed ID: 3755127 [TBL] [Abstract][Full Text] [Related]
27. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial. Tricarico D; Varricchio A; D'Ambrosio S; Ascione E; Motta G Arzneimittelforschung; 2004; 54(1):57-63. PubMed ID: 14979610 [TBL] [Abstract][Full Text] [Related]
28. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. Collet JP; Shapiro P; Ernst P; Renzi T; Ducruet T; Robinson A Am J Respir Crit Care Med; 1997 Dec; 156(6):1719-24. PubMed ID: 9412546 [TBL] [Abstract][Full Text] [Related]
29. Clinical experience with OM-85 BV in upper and lower respiratory tract infections. Derenne JP; Delclaux B Respiration; 1992; 59 Suppl 3():28-31. PubMed ID: 1439237 [TBL] [Abstract][Full Text] [Related]
30. Open comparative, randomized controlled clinical study of a new immunostimulating bacterial lysate in the prophylaxis of upper respiratory tract infections. Macchi A; Vecchia LD Arzneimittelforschung; 2005; 55(5):276-81. PubMed ID: 15960427 [TBL] [Abstract][Full Text] [Related]
31. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of oral immunotherapy on respiratory infections in hemodialysis patients: a double-blind, placebo-controlled study. Tielemans C; Gastaldello K; Husson C; Marchant A; Delville JP; Vanherweghem JL; Goldman M Clin Nephrol; 1999 Mar; 51(3):153-60. PubMed ID: 10099888 [TBL] [Abstract][Full Text] [Related]
33. Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What Is the Role of Antibiotics? Miravitlles M; Anzueto A Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28644389 [TBL] [Abstract][Full Text] [Related]
35. [ANTEAB: a study of early antibiotic therapy in intensive care management of acute exacerbations of chronic obstructive lung disease]. Fartoukh M; Similowski T; Brun-Buisson C; Rev Mal Respir; 2004 Apr; 21(2 Pt 1):381-9. PubMed ID: 15211249 [TBL] [Abstract][Full Text] [Related]
36. [Clinical efficacy of mechanical bacterial lysate in the prevention of infectious exacerbations of chronic obstructive pulmonary disease]. Avdeev SN; Nuralieva GS; Gainitdinova VV; Baimakanova GE; So AK; Merzhoeva ZM Ter Arkh; 2020 May; 92(4):57-63. PubMed ID: 32598699 [TBL] [Abstract][Full Text] [Related]
37. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data. Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101 [TBL] [Abstract][Full Text] [Related]
38. When should we put evidence into clinical practice? Türktaş I; Bakirtas A; Tapisiz A J Allergy Clin Immunol; 2011 Apr; 127(4):1078; author reply 1078-9. PubMed ID: 21306760 [No Abstract] [Full Text] [Related]
39. The cost-effectiveness of OM-85 in managing respiratory tract infections in China. Xuan J; Wang L; Yin H; Xuan D; Zhou Y; Hu S J Med Econ; 2015 Mar; 18(3):167-72. PubMed ID: 25275426 [TBL] [Abstract][Full Text] [Related]
40. [Experience with bronchomunal used in the combined treatment of patients with bronchial asthma and chronic obstructive pulmonary disease]. Antonova LP; Romanov VV; Averbakh MM Probl Tuberk Bolezn Legk; 2008; (4):8-11. PubMed ID: 18509908 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]